Science News Roundup: J&J's Stelara succeeds in chronic bowel disease study
Following is a summary of current science news briefs.
J&J's Stelara succeeds in chronic bowel disease study
Johnson & Johnson said on Tuesday its blockbuster drug Stelara was found to be effective in treating a chronic bowel disease in a late-stage trial. Two doses of Stelara, already approved for psoriasis, psoriatic arthritis and Crohn's disease, was tested in 961 patients with moderate-to-severe ulcerative colitis (UC) who had failed prior therapy.
(With inputs from agencies.)
Advertisement
ALSO READ
India's Success at UN: Elected to Key Bodies and Re-elected to International Narcotics Control Board
Traffic congestion on Navi Mumbai-Thane Belapur road after truck overturns
Is a Dominant Golfer Necessary for the Success of the Sport? It Depends on the Player
Proactive For Her Announces Expansion of Clinic Locations and Introduction of Fertility Services
South Korea's president faces a crucial referendum in parliamentary election